Product Information
RASUVO 12.5 MG/0.25 ML AUTOINJ is a brand product labeled by Medexus Pharma Inc., priced at $574.8679 per ML under NDC 59137051504. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/.25mL
Manufacturer
Medexus Pharma Inc.NDC
59137051504
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/1/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA205776On Market Since
7/10/2014
Pharmacological Classes
Price Statistics
The NADAC for RASUVO 12.5 MG/0.25 ML AUTOINJ has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $574.8679 per ML |
|---|---|
| All-time high | $574.8679 (Jun 24, 2026) |
| All-time low | $544.3717 (Mar 19, 2025) |
| 52-week high | $574.8679 |
| 52-week low | $559.9567 |
| Median price | $560.5082 |
| Average price | $555.7968 |
| Largest weekly change | +3.0% (Apr 2, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RASUVO 12.5 MG/0.25 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for RASUVO 12.5 MG/0.25 ML AUTOINJ, manufactured by Medexus Pharma Inc., is $574.8679 per ML (NDC 59137051504), effective Jun 24, 2026.
How has the price of RASUVO 12.5 MG/0.25 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for RASUVO 12.5 MG/0.25 ML AUTOINJ has risen 5.3%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RASUVO 12.5 MG/0.25 ML AUTOINJ?
Since Apr 17, 2024, the NADAC for RASUVO 12.5 MG/0.25 ML AUTOINJ has ranged from a low of $544.3717 (Mar 19, 2025) to a high of $574.8679 (Jun 24, 2026), with a median of $560.5082 per ML.
Are there cheaper alternatives to RASUVO 12.5 MG/0.25 ML AUTOINJ?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RASUVO 12.5 MG/0.25 ML AUTOINJ, so no direct lower-cost alternative is listed.
Who manufactures RASUVO 12.5 MG/0.25 ML AUTOINJ?
RASUVO 12.5 MG/0.25 ML AUTOINJ (NDC 59137051504) is labeled by Medexus Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification